303 related articles for article (PubMed ID: 29975207)
1. Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: A Systematic Review.
Liu L; Liu S; Wang C; Guan W; Zhang Y; Hu W; Zhang L; He Y; Lu J; Li T; Liu X; Xuan Y; Wang P
J Clin Rheumatol; 2019 Aug; 25(5):197-202. PubMed ID: 29975207
[TBL] [Abstract][Full Text] [Related]
2. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
[TBL] [Abstract][Full Text] [Related]
3. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Ghogomu ET; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
[TBL] [Abstract][Full Text] [Related]
4. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials.
Ortiz Z; Shea B; Suarez-Almazor ME; Moher D; Wells GA; Tugwell P
J Rheumatol; 1998 Jan; 25(1):36-43. PubMed ID: 9458200
[TBL] [Abstract][Full Text] [Related]
7. Folate supplementation during methotrexate therapy for rheumatoid arthritis.
Morgan SL; Baggott JE
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S102-9. PubMed ID: 21044441
[TBL] [Abstract][Full Text] [Related]
8. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.
van Ede AE; Laan RF; Rood MJ; Huizinga TW; van de Laar MA; van Denderen CJ; Westgeest TA; Romme TC; de Rooij DJ; Jacobs MJ; de Boo TM; van der Wilt GJ; Severens JL; Hartman M; Krabbe PF; Dijkmans BA; Breedveld FC; van de Putte LB
Arthritis Rheum; 2001 Jul; 44(7):1515-24. PubMed ID: 11465701
[TBL] [Abstract][Full Text] [Related]
9. Folate supplementation and methotrexate.
Dijkmans BA
Br J Rheumatol; 1995 Dec; 34(12):1172-4. PubMed ID: 8608361
[TBL] [Abstract][Full Text] [Related]
10. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.
Singh JA; Hossain A; Mudano AS; Tanjong Ghogomu E; Suarez-Almazor ME; Buchbinder R; Maxwell LJ; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2017 May; 5(5):CD012657. PubMed ID: 28481462
[TBL] [Abstract][Full Text] [Related]
11. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.
Prey S; Paul C
Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303
[TBL] [Abstract][Full Text] [Related]
12. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.
Whittle SL; Hughes RA
Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.
Hoekstra M; van Ede AE; Haagsma CJ; van de Laar MA; Huizinga TW; Kruijsen MW; Laan RF
Ann Rheum Dis; 2003 May; 62(5):423-6. PubMed ID: 12695153
[TBL] [Abstract][Full Text] [Related]
14. Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.
Baran W; Batycka-Baran A; Zychowska M; Bieniek A; Szepietowski JC
Expert Opin Drug Saf; 2014 Aug; 13(8):1015-21. PubMed ID: 24972718
[TBL] [Abstract][Full Text] [Related]
15. How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
Cansu DÜ; Teke HÜ; Bodakçi E; Korkmaz C
Clin Rheumatol; 2018 Dec; 37(12):3419-3425. PubMed ID: 30056523
[TBL] [Abstract][Full Text] [Related]
16. Folic and folinic acid supplementation reduces methotrexate gastrointestinal side effects in rheumatoid arthritis.
Pincus T
Clin Exp Rheumatol; 1998; 16(6):667-8. PubMed ID: 9844757
[No Abstract] [Full Text] [Related]
17. [Reducing toxicity of methotrexate with folic acid].
Harten P
Z Rheumatol; 2005 Jun; 64(5):353-8. PubMed ID: 15965822
[TBL] [Abstract][Full Text] [Related]
18. Purine enzymes in patients with rheumatoid arthritis treated with methotrexate.
van Ede AE; Laan RF; De Abreu RA; Stegeman AB; van de Putte LB
Ann Rheum Dis; 2002 Dec; 61(12):1060-4. PubMed ID: 12429535
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis.
Hartman M; van Ede A; Severens JL; Laan RF; van de Putte L; van der Wilt GJ
J Rheumatol; 2004 May; 31(5):902-8. PubMed ID: 15124248
[TBL] [Abstract][Full Text] [Related]
20. The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis.
Li X; Hu M; Li W; Gu L; Chen M; Ding H; Vanarsa K; Du Y
Int Immunopharmacol; 2016 Sep; 38():8-15. PubMed ID: 27233001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
